Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Anteris Technologies Global Corp./ 10-K

Annual Report · 10-K

Anteris Technologies Global Corp.

AVRNASDAQEQUITYCurrent

Annual Report

Filed Feb 26, 2026Accepted Feb 26, 2026, 4:07 PM ESTCIK 2011514Accession 0001140361-26-006977
View company →Permanent SEC source ↗
Share

Company context

Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA, Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients.

Current securities

AVRNASDAQ · EQUITY · Current

Recent company filings

  1. 424B3 filingSep 24, 2026
  2. Entry into a Material Definitive AgreementSep 23, 2026
  3. 424B3 filingSep 21, 2026
  4. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 17, 2026
  5. 4 filingSep 16, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗